Am J Respir Crit Care Med

1. GAUSI K, Ignatius EH, De Jager V, Upton C, et al
   High-Dose Isoniazid Lacks EARLY Bactericidal Activity Against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized, Phase 2 Clinical Trial.
   Am J Respir Crit Care Med. 2024 Apr 2. doi: 10.1164/rccm.202311-2004.
   

   >> Share

   
   

   
   Ann Intern Med

2. LI Y, Regan M, Swartwood NA, Barham T, et al
   Disparities in Tuberculosis Incidence by Race and Ethnicity Among the U.S.-Born Population in the United States, 2011 to 2021 : An Analysis of National Disease Registry Data.
   Ann Intern Med. 2024 Apr 2. doi: 10.7326/M23-2975.
   

   >> Share

   
   
3. CASTRO KG, Shah NS
   Beyond the Bacillus: Closing Gaps in Tuberculosis Health Disparities Requires Targeting Social Determinants.
   Ann Intern Med. 2024 Apr 2. doi: 10.7326/M24-0548.
   

   >> Share

   
   

   
   Clin Infect Dis

4. RODRIGUEZ-MOLINO P, Tebruegge M, Noguera-Julian A, Neth O, et al
   Tuberculosis disease in immunocompromised children and adolescents: a pTBnet multi-centre case-control study.
   Clin Infect Dis. 2024 Apr 3:ciae158. doi: 10.1093.
   

   >> Share

   
   

   
   Emerg Infect Dis

5. GURREY SO, Strick LB, Dov LK, Miller JS, et al
   Lessons Learned from Public Health and State Prison Collaborations during COVID-19 Pandemic and Multifacility Tuberculosis Outbreak, Washington, USA.
   Emerg Infect Dis. 2024;30:S17-S20.
   

   >> Share

   
   

   
   Eur Respir J

6. NOGUERA-JULIAN A, Latre C, Flores A
   Availability of paediatric dispersible fixed-dose combinations of tuberculosis drugs in Spain.
   Eur Respir J. 2024;63:2400104.
   

   >> Share

   
   

   
   Int J Tuberc Lung Dis

7. SHAIKH A, Sriraman K, Vaswani S, Shah I, et al
   SMaRT-PCR: sampling using masks and RT-PCR, a non-invasive diagnostic tool for paediatric pulmonary TB.
   Int J Tuberc Lung Dis. 2024;28:189-194.
   

   >> Share

   
   
8. KAWATSU L, Uchimura K, Schwalb A, Houben R, et al
   New perspectives on the secular trend in pulmonary TB in post-war Japan (1953-1980).
   Int J Tuberc Lung Dis. 2024;28:207-209.
   

   >> Share

   
   
9. MARKS SM, Winston CA
   Estimated treatment costs for multidrug-resistant TB in the United States.
   Int J Tuberc Lung Dis. 2024;28:214-215.
   

   >> Share

   
   
10. ILAIWY G, Heysell SK, Lukumay S, Agustino D, et al
    Cash transfers to enhance completion of TB screening among household contacts in rural Tanzania.
    Int J Tuberc Lung Dis. 2024;28:176-182.
    

    >> Share

    
    
11. DOGO FM, Ate S, Agossou K, Menon S, et al
    Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo.
    Int J Tuberc Lung Dis. 2024;28:195-201.
    

    >> Share

    
    
12. PARREIRA PL, Fonseca AU, Soares F, Conte MB, et al
    Chest X-ray evaluation using machine learning to support the early diagnosis of pulmonary TB.
    Int J Tuberc Lung Dis. 2024;28:171-175.
    

    >> Share

    
    

    
    J Antimicrob Chemother

13. VAN INGEN J
    Why do we use 100 mg of clofazimine in TB and NTM treatment?
    J Antimicrob Chemother. 2024;79:697-702.
    

    >> Share

    
    

    
    J Infect

14. LIANG Q, Jiang X, Jia J, Zhao L, et al
    An early and trustable indicator suggestive of non-tuberculosis mycobacteria isolation in a high Tuberculosis burden setting.
    J Infect. 2024 Apr 2:106149. doi: 10.1016/j.jinf.2024.106149.
    

    >> Share

    
    

    
    J Infect Dis

15. TAIT D, Diacon A, Borges AH, van Brakel E, et al
    Safety and immunogenicity of the H56:IC31 tuberculosis vaccine candidate in adults successfully treated for drug-susceptible pulmonary TB: a phase 1 randomized trial.
    J Infect Dis. 2024 Apr 1:jiae170. doi: 10.1093.
    

    >> Share

    
    

    
    PLoS One

16. PERESU E, De Graeve D, Heunis JC, Kigozi NG, et al
    Cost-consequence analysis of ambulatory clinic- and home-based multidrug-resistant tuberculosis management models in Eswatini.
    PLoS One. 2024;19:e0301507.
    

    >> Share

    
    
17. CAI N, Luo W, Ding L, Chen L, et al
    Obesity-related indicators and tuberculosis: A Mendelian randomization study.
    PLoS One. 2024;19:e0297905.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share